BIOMERICA INC (BMRA) is a publicly traded Healthcare sector company. As of May 21, 2026, BMRA trades at $2.35 with a market cap of $6.95M and a P/E ratio of -0.93. BMRA moved +0.00% today. Year to date, BMRA is -9.62%; over the trailing twelve months it is -35.44%. Its 52-week range spans $1.87 to $10.16. Rallies surfaces BMRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded BMRA stock?
Rallies tracks politician and congressional stock disclosures for BMRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Irani Zackary S. bought 200 (~$310) on May 25, 2023.
Irani Zackary S. bought 500 (~$805) on May 24, 2023.
Irani Zackary S. bought 1.70K (~$1.99K) on May 12, 2023.
BMRA Analyst Consensus
BMRA analyst coverage data. Average price target: $0.00.
Common questions about BMRA
Which politicians traded BMRA stock?
Rallies tracks politician and congressional stock disclosures for BMRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in BMRA?
Yes. Rallies tracks politician and congressional stock disclosures for BMRA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BMRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMRA. It does not provide personalized investment advice.
